| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |